AIM ImmunoTech logo
AIM ImmunoTech AIM
$ 0.87 -10.65%

Quarterly report 2025-Q3
added 11-17-2025

report update icon

AIM ImmunoTech Operating Cycle 2011-2026 | AIM

Annual Operating Cycle AIM ImmunoTech

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- 46 0.0761 2.14 K 1.09 K 20 - 303 - - 83.1 314

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
2.14 K 0.0761 499

Quarterly Operating Cycle AIM ImmunoTech

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - - - - - - - 80.3 - - - - - - - 77.4 123 111 - 86.2 77.6 79.1 - 65.8 138 - - 564 650 211 - 24.3 10.3 13 - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
650 10.3 154

Operating Cycle of other stocks in the Biotechnology industry

Issuer Operating Cycle Price % 24h Market Cap Country
Aeterna Zentaris Aeterna Zentaris
AEZS
115 - 5.93 % $ 314 M canadaCanada
Albireo Pharma Albireo Pharma
ALBO
40.8 - -0.23 % $ 916 M usaUSA
I-Mab I-Mab
IMAB
271 - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
12.8 - - $ 40.3 B usaUSA
Aptinyx Aptinyx
APTX
46.9 - -39.0 % $ 4.57 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
245 - -18.52 % $ 27.3 M britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
32 - -1.52 % $ 24.7 M usaUSA
Processa Pharmaceuticals Processa Pharmaceuticals
PCSA
723 $ 2.37 1.72 % $ 3.1 M usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
237 $ 19.6 1.92 % $ 916 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
61.7 - - $ 7.46 M israelIsrael
AgeX Therapeutics AgeX Therapeutics
AGE
78.4 - -10.17 % $ 12.2 K usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
394 - -24.86 % $ 820 K usaUSA
Acasti Pharma Acasti Pharma
ACST
1.97 - 4.01 % $ 150 M canadaCanada
BeiGene, Ltd. BeiGene, Ltd.
BGNE
52.6 - 0.49 % $ 251 B cayman-islandsCayman-islands
bluebird bio bluebird bio
BLUE
127 - - $ 546 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
104 - - - russiaRussia
Cara Therapeutics Cara Therapeutics
CARA
52.4 - -3.03 % $ 260 M usaUSA
Phathom Pharmaceuticals Phathom Pharmaceuticals
PHAT
192 $ 10.35 2.88 % $ 755 M usaUSA
Advaxis Advaxis
ADXS
88.1 - -9.65 % $ 45.9 M usaUSA
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
1.1 K $ 47.4 2.09 % $ 4.26 B schweizSchweiz
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCC
185 - -5.98 % $ 34.1 M usaUSA
ChemoCentryx ChemoCentryx
CCXI
3.1 - - $ 3.74 B usaUSA
Pliant Therapeutics Pliant Therapeutics
PLRX
37.6 $ 1.32 3.13 % $ 81 M usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
512 - - $ 2.02 B usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
436 - -4.8 % $ 255 M usaUSA
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
50 $ 4.51 4.76 % $ 864 M canadaCanada